Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Enovis Corp (ENOV)

Enovis Corp (ENOV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,457,463
  • Shares Outstanding, K 57,539
  • Annual Sales, $ 2,248 M
  • Annual Income, $ -1,184 M
  • EBIT $ 99 M
  • EBITDA $ 1,443 M
  • 60-Month Beta 1.47
  • Price/Sales 0.64
  • Price/Cash Flow 0.94
  • Price/Book 0.96

Options Overview Details

View History
  • Implied Volatility 61.27% (-1.79%)
  • Historical Volatility 48.13%
  • IV Percentile 33%
  • IV Rank 29.37%
  • IV High 109.75% on 02/02/26
  • IV Low 41.11% on 06/20/25
  • Expected Move (DTE 1) 0.00 (0.00%)
  • Put/Call Vol Ratio 0.60
  • Today's Volume 16
  • Volume Avg (30-Day) 206
  • Put/Call OI Ratio 0.07
  • Today's Open Interest 14,284
  • Open Int (30-Day) 13,327
  • Expected Range 25.20 to 25.20

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 13 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate $0.82
  • Number of Estimates 2
  • High Estimate $0.83
  • Low Estimate $0.81
  • Prior Year $0.81
  • Growth Rate Est. (year over year) +1.23%

Price Performance

See More
Period Period Low Period High Performance
1-Month
21.40 +17.76%
on 03/20/26
25.95 -2.89%
on 04/16/26
+1.99 (+8.57%)
since 03/16/26
3-Month
21.00 +20.00%
on 01/29/26
26.41 -4.58%
on 02/27/26
+1.23 (+5.13%)
since 01/16/26
52-Week
21.00 +20.00%
on 01/29/26
37.85 -33.42%
on 05/13/25
-5.96 (-19.13%)
since 04/16/25

Most Recent Stories

More News
Enovis to Host First Quarter 2026 Results Conference Call on May 7th

Dallas, TX, April 10, 2026 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, announced that it will host an investor conference call and...

ENOV : 25.20 (-0.51%)
1 Value Stock to Research Further and 2 We Turn Down

1 Value Stock to Research Further and 2 We Turn Down

ENOV : 25.20 (-0.51%)
MAS : 63.73 (+0.89%)
LDOS : 156.47 (-1.62%)
3 Healthcare Stocks with Open Questions

3 Healthcare Stocks with Open Questions

ENOV : 25.20 (-0.51%)
HSIC : 77.21 (-0.27%)
MYGN : 5.00 (-3.66%)
Enovis, Neogen, Humana, LifeStance Health Group, and Hims & Hers Health Stocks Trade Down, What You Need To Know

Enovis, Neogen, Humana, LifeStance Health Group, and Hims & Hers Health Stocks Trade Down, What You Need To Know

ENOV : 25.20 (-0.51%)
HUM : 200.76 (+1.20%)
HIMS : 26.99 (+11.12%)
LFST : 6.67 (+1.83%)
NEOG : 9.24 (-1.91%)
Unpacking Q4 Earnings: Enovis (NYSE:ENOV) In The Context Of Other Medical Devices & Supplies - Specialty Stocks

Unpacking Q4 Earnings: Enovis (NYSE:ENOV) In The Context Of Other Medical Devices & Supplies - Specialty Stocks

ENOV : 25.20 (-0.51%)
3 Unprofitable Stocks We Approach with Caution

3 Unprofitable Stocks We Approach with Caution

ENOV : 25.20 (-0.51%)
PACB : 1.6300 (+1.87%)
KRUS : 56.78 (-5.37%)
Why Enovis (ENOV) Stock Is Trading Up Today

Why Enovis (ENOV) Stock Is Trading Up Today

ENOV : 25.20 (-0.51%)
Enovis: Q4 Earnings Snapshot

Enovis: Q4 Earnings Snapshot

ENOV : 25.20 (-0.51%)
Update: Enovis Announces Fourth Quarter and Full Year 2025 Results

Continued commercial momentum with full year 2025 sales growth of  7% on a reported basis and 6% organically Full year 2025 Reconstructive sales grew 10% Y/Y on a reported basis and...

ENOV : 25.20 (-0.51%)
Enovis (NYSE:ENOV) Misses Q4 CY2025 Sales Expectations

Enovis (NYSE:ENOV) Misses Q4 CY2025 Sales Expectations

ENOV : 25.20 (-0.51%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Enovis Corporation is a medical technology company. Its range of products, services and integrated technologies fuel active lifestyles in orthopedics and beyond. Enovis Corporation, formerly known as Colfax Corporation, is based in Wilmington, DE.

See More

Key Turning Points

3rd Resistance Point 26.50
2nd Resistance Point 26.23
1st Resistance Point 25.71
Last Price 25.20
1st Support Level 24.92
2nd Support Level 24.65
3rd Support Level 24.13

See More

52-Week High 37.85
Fibonacci 61.8% 31.41
Fibonacci 50% 29.42
Fibonacci 38.2% 27.44
Last Price 25.20
52-Week Low 21.00

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.